K. Sorenmo

发表

J. Webster, J. Cullen, J. Kirpensteijn, 2011, Veterinary pathology.

Characterization of Mammary Tumors Using Noninvasive Tactile and Hyperspectral Sensors

Amir Hossein Harati Nejad Torbati, Firdous Saleheen, Vira Oleksyuk, 2014, IEEE Sensors Journal.

Evaluation of Clostridium novyi-NT spores in dogs with naturally occurring tumors.

K. Kinzler, B. Vogelstein, L. Diaz, 2012, American journal of veterinary research.

Effect of Ovariohysterectomy at the Time of Tumor Removal in Dogs with Mammary Carcinomas: A Randomized Controlled Trial

E. Skjerve, M. Goldschmidt, L. Peña, 2015, Journal of veterinary internal medicine.

Effect of ovariohysterectomy at the time of tumor removal in dogs with benign mammary tumors and hyperplastic lesions: a randomized controlled clinical trial.

T. Grotmol, M. Goldschmidt, T. J. Jonasdottir, 2013, Journal of veterinary internal medicine.

Effect of spaying and timing of spaying on survival of dogs with mammary carcinoma.

F. Shofer, M. Goldschmidt, K. Sorenmo, 2000, Journal of veterinary internal medicine.

The estrogen effect; clinical and histopathological evidence of dichotomous influences in dogs with spontaneous mammary carcinomas

E. Radaelli, M. Goldschmidt, L. Peña, 2019, PloS one.

CD40-Activated B Cell Cancer Vaccine Improves Second Clinical Remission and Survival in Privately Owned Dogs with Non-Hodgkin's Lymphoma

R. Vonderheide, K. Sorenmo, C. M. Coughlin, 2011, PloS one.

Liposarcomas in dogs: 56 cases (1989-2000).

M. Hendrick, F. Shofer, K. Sorenmo, 2004, Journal of the American Veterinary Medical Association.

Modeling molecular development of breast cancer in canine mammary tumors

David G. Robinson, John D. Storey, Chandra L. Theesfeld, 2020, Genome research.

Case-control study to evaluate risk factors for the development of sepsis (neutropenia and fever) in dogs receiving chemotherapy.

K. Drobatz, K. Sorenmo, L. King, 2010, Journal of the American Veterinary Medical Association.

Assessment of Cyclooxygenase-2 Expression in Canine Hemangiosarcoma, Histiocytic Sarcoma, and Mast Cell Tumor

M. Goldschmidt, D. Holt, K. Sorenmo, 2005, Veterinary pathology.

Chapter 69 – Pulmonary and Bronchial Neoplasia

K. Sorenmo, J. Baez, 2004 .

Chapter 57 – A Review and Update on Gastrointestinal Lymphoma in Cats

K. Sorenmo, E. Krick, 2016 .

RNA-loaded CD40-activated B cells stimulate antigen-specific T-cell responses in dogs with spontaneous lymphoma

A. Zurbriggen, R. Vonderheide, K. Sorenmo, 2008, Gene Therapy.

Outcome and toxicity associated with a dose-intensified, maintenance-free CHOP-based chemotherapy protocol in canine lymphoma: 130 cases.

F. Shofer, K. Sorenmo, T. Ferrara, 2010, Veterinary and comparative oncology.

A prospective investigation of the prevalence and prognostic significance of weight loss and changes in body condition in feline cancer patients⋆

F. Shofer, K. Michel, K. Sorenmo, 2007, Journal of feline medicine and surgery.

Cyclooxygenase-2 Expression is Associated with Histologic Tumor Type in Canine Mammary Carcinoma

F. Shofer, M. Goldschmidt, D. Holt, 2005, Veterinary pathology.

Magnetic resonance imaging of focal splenic and hepatic lesions in the dog.

E. Pretorius, E. Siegelman, J. Solomon, 2004, Journal of veterinary internal medicine.

Association between ovarihysterectomy and feline mammary carcinoma.

F. Shofer, M. Goldschmidt, K. Sorenmo, 2005, Journal of veterinary internal medicine.

A prospective randomized trial of desmopressin in canine mammary carcinoma.

D. Stefanovski, K. Sorenmo, A. Durham, 2020, Veterinary and comparative oncology.

Polyamine Inhibitors for Treatment of Feline Oral Squamous Cell Carcinoma: A Proof-of-Concept Study

K. Sorenmo, J. R. Lewis, A. Reiter, 2013, Journal of veterinary dentistry.

Evaluation of factors associated with prolonged hospital stay and outcome of febrile neutropenic patients receiving chemotherapy: 70 cases (1997-2010).

K. Sorenmo, T. Gregor, M. Kelleher, 2014, Veterinary and comparative oncology.

Immunohistochemical characterization of canine prostatic carcinoma and correlation with castration status and castration time.

F. Shofer, M. Goldschmidt, K. Sorenmo, 2003, Veterinary and comparative oncology.

Clinical and pharmacokinetic characteristics of intracavitary administration of pegylated liposomal encapsulated doxorubicin in dogs with splenic hemangiosarcoma.

R. Poppenga, F. Shofer, T. V. Van Winkle, 2007, Journal of veterinary internal medicine.

Prognosis for presumed feline vaccine-associated sarcoma after excision: 61 cases (1986-1996).

A. Hershey, M. Hendrick, F. Shofer, 2000, Journal of the American Veterinary Medical Association.

Risk factors for development of sterile haemorrhagic cystitis in canine lymphoma patients receiving oral cyclophosphamide: a case-control study.

R. Cohen, K. Sorenmo, D. Brown, 2014, Veterinary and comparative oncology.

Early Tumor Response to Intraarterial or Intravenous Administration of Carboplatin to Treat Naturally Occurring Lower Urinary Tract Carcinoma in Dogs

P. Kass, K. Sorenmo, C. Weisse, 2015, Journal of veterinary internal medicine.

Efficacy of doxorubicin-based chemotherapy for non-resectable canine subcutaneous haemangiosarcoma.

K. Sorenmo, T. Gregor, C. Clifford, 2010, Veterinary and comparative oncology.

Efficacy and toxicity of a dose-intensified doxorubicin protocol in canine hemangiosarcoma.

F. Shofer, E. Mauldin, K. Sorenmo, 2004, Journal of veterinary internal medicine.

Canine hemangiosarcoma treated with standard chemotherapy and minocycline.

F. Shofer, L. Barber, M. Goldschmidt, 2000, Journal of veterinary internal medicine.

Chemotherapy of canine hemangiosarcoma with doxorubicin and cyclophosphamide.

S. Helfand, K. Sorenmo, K. A. Jeglum, 1993, Journal of veterinary internal medicine.

Recurrence rates and sites for grade II canine cutaneous mast cell tumors following complete surgical excision.

F. Shofer, K. Sorenmo, C. Weisse, 2002, Journal of the American Animal Hospital Association.

Feline epitheliotropic intestinal malignant lymphoma: 10 cases (1997-2000).

K. Drobatz, K. Sorenmo, Karin U Sørenmo, 2003, Journal of veterinary internal medicine.

Chapter 84 – Neoplasms of the Cranial Mediastinum and Pleura

K. Sorenmo, J. Carreras, 2004 .

27 – Tumors of the Mammary Gland

D. Worley, M. Goldschmidt, K. Sorenmo, 2013 .

Combined doxorubicin and cyclophosphamide chemotherapy for nonresectable feline fibrosarcoma.

F. Shofer, L. Barber, K. Cronin, 2000, Journal of the American Animal Hospital Association.

Characterisation of the signalment, clinical and survival characteristics of 41 cats with mast cell neoplasia⋆

K. Sorenmo, A. Litster, 2006, Journal of feline medicine and surgery.

Treatment outcomes and prognostic factors of feline splenic mast cell tumors: A multi‐institutional retrospective study of 64 cases

K. Sorenmo, T. Gregor, S. Allstadt, 2018, Veterinary and comparative oncology.

Evaluation of adjuvant doxorubicin-based chemotherapy for the treatment of feline mammary carcinoma.

F. Shofer, L. Barber, K. Sorenmo, 2009, Journal of veterinary internal medicine.

Clinical, histopathological and immunohistochemical characterization of canine indolent lymphoma.

M. D. Sánchez, K. Sorenmo, T. Gregor, 2013, Veterinary and comparative oncology.

Sensitivity and specificity of methods of assessing the regional lymph nodes for evidence of metastasis in dogs and cats with solid tumors.

M. Hendrick, F. Shofer, P. McManus, 2001, Journal of the American Veterinary Medical Association.

Development, Anatomy, Histology, Lymphatic Drainage, Clinical Features, and Cell Differentiation Markers of Canine Mammary Gland Neoplasms

V. Zappulli, M. Goldschmidt, R. Rasotto, 2011, Veterinary pathology.

Canine mammary gland tumours; a histological continuum from benign to malignant; clinical and histopathological evidence.

F. Shofer, M. Goldschmidt, K. Sorenmo, 2009, Veterinary and comparative oncology.

Outcomes of dogs with grade 3 mast cell tumors: 43 cases (1997-2007).

L. Rigatti, M. Kiupel, F. Shofer, 2011, Journal of the American Animal Hospital Association.

Cytological lymph node evaluation in dogs with mast cell tumours: association with grade and survival.

F. Shofer, K. Sorenmo, E. Krick, 2009, Veterinary and comparative oncology.

Prospective clinical trial to compare vincristine and vinblastine in a COP-based protocol for lymphoma in cats.

R. Cohen, K. Sorenmo, T. Gregor, 2013, Journal of veterinary internal medicine.

Clinical characteristics of mammary carcinoma in male cats.

F. Shofer, M. Goldschmidt, K. Sorenmo, 2005, Journal of veterinary internal medicine.

Characteristics of the Epithelial-Mesenchymal Transition in Primary and Paired Metastatic Canine Mammary Carcinomas

E. Puré, R. Laufer-Amorim, K. Sorenmo, 2018, Veterinary pathology.

Evaluation of histological grade and histologically tumour-free margins as predictors of local recurrence in completely excised canine mast cell tumours.

M. Goldschmidt, D. C. Brown, K. Sorenmo, 2015, Veterinary and comparative oncology.

Markers of Canine Mammary Gland Neoplasms Development , Anatomy , Histology , Lymphatic Drainage , Clinical Features , and Cell Differentiation

V. Zappulli, M. Goldschmidt, R. Rasotto, 2011 .

Canine mammary gland tumors.

K. Sorenmo, Karin Sorenmo, 2003, The Veterinary clinics of North America. Small animal practice.

Effect of spaying and timing of spaying on survival of dogs with mammary carcinoma

F. Shofer, M. Goldschmidt, K. Sorenmo, 2000 .

retrospective study of 23 cases? Rescue therapy with doxorubicin-based chemotherapy for relapsing or refractory feline lymphoma: A

E. Mauldin, P. McManus, K. Sorenmo, 2012 .

Rescue therapy with doxorubicin-based chemotherapy for relapsing or refractory feline lymphoma: A retrospective study of 23 cases⋆

E. Mauldin, P. McManus, K. Sorenmo, 2009, Journal of feline medicine and surgery.

Mammary adenocarcinomas in three male cats exposed to medroxyprogesterone acetate (1990–2006)

K. Sorenmo, T. Jacobs, J. Ferracone, 2010, Journal of feline medicine and surgery.

Evaluation of cyclooxygenase-1 and cyclooxygenase-2 expression and the effect of cyclooxygenase inhibitors in canine prostatic carcinoma.

F. Shofer, M. Goldschmidt, K. Sorenmo, 2004, Veterinary and comparative oncology.

Collagen molecular phenotypic switch between non-neoplastic and neoplastic canine mammary tissues

M. Yamauchi, K. Uzawa, S. Hattori, 2021, Scientific Reports.

Characterization of the biological behaviour of appendicular osteosarcoma in Rottweilers and a comparison with other breeds: a review of 258 dogs.

F. Shofer, M. Kent, T. V. Van Winkle, 2007, Veterinary and comparative oncology.

Extraskeletal osteosarcomas in dogs: a retrospective study of 169 cases (1986-1996).

D. Dambach, M. Anderson, K. Sorenmo, 1998, Journal of the American Animal Hospital Association.

Evaluation of body condition and weight loss in dogs presented to a veterinary oncology service.

F. Shofer, K. Michel, K. Sorenmo, 2004, Journal of veterinary internal medicine.

Vascular endothelial growth factor concentrations in body cavity effusions in dogs.

D. Hughes, K. Drobatz, C. Henry, 2002, Journal of veterinary internal medicine.

Intratumoral collagen signatures predict clinical outcomes in feline mammary carcinoma

D. Stefanovski, K. Sorenmo, A. Durham, 2020, PloS one.

Description of clinical and pathological findings, treatment and outcome of feline large granular lymphocyte lymphoma (1996-2004).

K. Sorenmo, C. Clifford, J. Baez, 2008, Veterinary and comparative oncology.

Plasma vascular endothelial growth factor concentrations in healthy dogs and dogs with hemangiosarcoma.

D. Hughes, C. Henry, K. Sorenmo, 2001, Journal of veterinary internal medicine.

CCNU for the Treatment of Dogs with Histiocytic Sarcoma

C. Couto, M. Paoloni, F. Shofer, 2007 .

Launching a Novel Preclinical Infrastructure: Comparative Oncology Trials Consortium Directed Therapeutic Targeting of TNFα to Cancer Vasculature

S. Libutti, W. Arap, D. Thamm, 2009, PloS one.

Investigating Associations Between Proliferation Indices, C-kit, and Lymph Node Stage in Canine Mast Cell Tumors.

M. Kiupel, K. Sorenmo, Dorothy C Brown, 2017, Journal of the American Animal Hospital Association.

Treating the locoregional lymph nodes with radiation and/or surgery significantly improves outcome in dogs with high-grade mast cell tumors.

K. Drobatz, K. Sorenmo, L. Kubicek, 2020, Veterinary and comparative oncology.

Identification of prognostic collagen signatures and potential therapeutic stromal targets in canine mammary gland carcinoma

Veronica Kristiansen, E. Puré, G. Ruthel, 2017, PloS one.

Developing and testing prognostic bio-scoring systems for canine mammary gland carcinomas.

M. Goldschmidt, L. Peña, D. Stefanovski, 2019, Veterinary and comparative oncology.

Cystosonographic measurements of canine bladder tumours.

F. Shofer, K. Sorenmo, G. Seiler, 2010, Veterinary and comparative oncology.

A prospective randomized trial of desmopressin in canine mammary carcinoma.

K. Sorenmo, 2020, Veterinary and comparative oncology.

CCNU for the treatment of dogs with histiocytic sarcoma.

C. Couto, M. Paoloni, F. Shofer, 2007, Journal of veterinary internal medicine.

Association between macroscopic appearance of liver lesions and liver histology in dogs with splenic hemangiosarcoma: 79 cases (2004-2009).

P. Bergman, K. Sorenmo, T. Donovan, 2014, Journal of the American Animal Hospital Association.

Hyperspectral imaging system to discern malignant and benign canine mammary tumors

Chang-Hee Won, Amrita Sahu, Cushla M. McGoverin, 2013, Defense, Security, and Sensing.

Pulmonary fibrosis after high cumulative dose nitrosourea chemotherapy in a cat.

K. Sorenmo, A. Durham, K. Skorupski, 2008, Veterinary and comparative oncology.

Prognostic Significance of Weight Changes during Treatment of Feline Lymphoma⋆

Reneé H Moore, K. Sorenmo, E. Krick, 2011, Journal of feline medicine and surgery.

Diagnosis and Multimodal Treatment of Metastatic Maxillofacial Juvenile Embryonal Rhabdomyosarcoma in a Young Golden Retriever.

K. Sorenmo, J. Gillem, L. Sullivan, 2018, Journal of the American Animal Hospital Association.

Case-control study to evaluate risk factors for the development of sepsis (neutropenia and fever) in dogs receiving chemotherapy.

K. Drobatz, K. Sorenmo, L. King, 2010, Journal of the American Veterinary Medical Association.

Response-based modification of CHOP chemotherapy for canine B-cell lymphoma.

N. Keuler, A. Avery, M. Atherton, 2021, Veterinary and comparative oncology.

Corrigendum to “A prospective investigation of the prevalence and prognostic significance of weight loss and changes in body condition in feline cancer patients” [Journal of Feline Medicine and Surgery 9 (2007) 411–417]

F. Shofer, K. Michel, K. Sorenmo, 2007 .